Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| cbdMD, Inc.YCBD · Entity 8230 | Former CFO/COO | October 01, 2020 | October 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
cbdMD, Inc.
Report date October 01, 2020 · Filed October 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2020-10-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 50,000 |
| Common stockSEC Table I · non-derivative | IndirectSee footnote | 1,680 |
Reported balance
Holding disclosure · report date 2020-10-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,680 F1: The number of shares of common stock beneficially owned by the Reporting Person includes 1,680 shares owned of record by his spouse's retirement account. |
| Stock optionSEC Table II · derivative / convertible security · Conversion / exercise price $4.00 · Expires 2024-05-01 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2020-10-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 50,000 F2: Stock option grants were previously made by the Issuer to the Reporting Person under the Issuer's 2015 Equity Compensation Plan as additional compensation to the Reporting Person. |
| Stock optionSEC Table II · derivative / convertible security · Conversion / exercise price $4.00 · Expires 2024-05-01 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2020-10-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 50,000 F2: Stock option grants were previously made by the Issuer to the Reporting Person under the Issuer's 2015 Equity Compensation Plan as additional compensation to the Reporting Person. |
| Stock optionSEC Table II · derivative / convertible security · Conversion / exercise price $7.50 · Expires 2024-05-01 | Direct | 100,000 |
Reported balance
Holding disclosure · report date 2020-10-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 100,000 F2: Stock option grants were previously made by the Issuer to the Reporting Person under the Issuer's 2015 Equity Compensation Plan as additional compensation to the Reporting Person. |
| Stock optionSEC Table II · derivative / convertible security · Conversion / exercise price $4.78 · Expires 2028-05-29 | Direct | 75,000 |
Reported balance
Holding disclosure · report date 2020-10-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 75,000 F2: Stock option grants were previously made by the Issuer to the Reporting Person under the Issuer's 2015 Equity Compensation Plan as additional compensation to the Reporting Person. |
| Stock optionSEC Table II · derivative / convertible security · Conversion / exercise price $4.78 · Expires 2028-05-29 | Direct | 75,000 |
Reported balance
Holding disclosure · report date 2020-10-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 75,000 F2: Stock option grants were previously made by the Issuer to the Reporting Person under the Issuer's 2015 Equity Compensation Plan as additional compensation to the Reporting Person. |
| Stock optionSEC Table II · derivative / convertible security · Conversion / exercise price $2.60 · Expires 2023-09-16 | Direct | 300,000 |
Reported balance
Holding disclosure · report date 2020-10-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 300,000 F2: Stock option grants were previously made by the Issuer to the Reporting Person under the Issuer's 2015 Equity Compensation Plan as additional compensation to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: The number of shares of common stock beneficially owned by the Reporting Person includes 1,680 shares owned of record by his spouse's retirement account.
F2: Stock option grants were previously made by the Issuer to the Reporting Person under the Issuer's 2015 Equity Compensation Plan as additional compensation to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2020 Filed Sep 18, 2020 17:30 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Option · Derivative | 300,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001654954-20-010247 · section16.xml · derivative · entry 1 Elliott Mark S · CIK 0001309100 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2023-09-16 Read SEC document |
| January 27, 2020 Filed Feb 25, 2020 16:30 UTC | cbdMD, Inc. YCBD · Entity 8230 | PurchaseCommon stock | 5,000 | $1.06 | $5,300.00 |
DisclosureSEC source: 0001654954-20-001917 · section16.xml · nonDerivative · entry 1 Elliott Mark S · CIK 0001309100 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 51,680 F1 · ownership.direct: The number of shares acquired by Mr. Elliott as reported in this Form 4 were purchased by him individually. The number of shares of common stock beneficially owned by Mr. Elliott after giving effect to this acquisition includes (i) 50,000 shares held by him directly, and (ii) 1,680 shares held by his spouse. F1 · ownership.nature: The number of shares acquired by Mr. Elliott as reported in this Form 4 were purchased by him individually. The number of shares of common stock beneficially owned by Mr. Elliott after giving effect to this acquisition includes (i) 50,000 shares held by him directly, and (ii) 1,680 shares held by his spouse. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 07:00 UTC | cbdMD, Inc. YCBD · Entity 8230 | PurchaseCommon Stock | 15,000 | $1.00 | $15,000.00 |
DisclosureSEC source: 0001654954-20-000506 · section16.xml · nonDerivative · entry 1 Elliott Mark S · CIK 0001309100 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 46,680 F1 · ownership.nature: The number of shares acquired by Mr. Elliott as reported in this Form 4 were purchased by him individually. The number of shares of common stock beneficially owned by Mr. Elliott after giving effect to this acquisition includes (i) 45,000 shares held by him directly, and (ii) 1,680 shares held by his spouse. Read SEC document |
| May 29, 2018 Filed May 31, 2018 12:49 UTC | cbdMD, Inc. LEVB · Entity 8230 | GrantOptions grant · Derivative | 0 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001654954-18-006090 · section16.xml · derivative · entry 2 Elliott Mark S · CIK 0001309100 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: common stock · 75,000 shares Expires 2028-05-29 Read SEC document |
| May 29, 2018 Filed May 31, 2018 12:49 UTC | cbdMD, Inc. LEVB · Entity 8230 | GrantOptions grant · Derivative | 0 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001654954-18-006090 · section16.xml · derivative · entry 1 Elliott Mark S · CIK 0001309100 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: common sotck · 75,000 shares Expires 2028-05-29 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.